• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类药物转换:等效镇痛剂量表的科学依据与局限性

Opioid rotation: the science and the limitations of the equianalgesic dose table.

作者信息

Knotkova Helena, Fine Perry G, Portenoy Russell K

机构信息

Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY, USA.

出版信息

J Pain Symptom Manage. 2009 Sep;38(3):426-39. doi: 10.1016/j.jpainsymman.2009.06.001.

DOI:10.1016/j.jpainsymman.2009.06.001
PMID:19735903
Abstract

Opioid rotation refers to a switch from one opioid to another in an effort to improve the response to analgesic therapy or reduce adverse effects. It is a common method to address the problem of poor opioid responsiveness despite optimal dose titration. Guidelines for opioid rotation are empirical and begin with the selection of a safe and reasonably effective starting dose for the new opioid, followed by dose adjustment to optimize the balance between analgesia and side effects. The selection of a starting dose must be based on an estimate of the relative potency between the existing opioid and the new one. Potency, which is defined as the dose required to produce a given effect, differs widely among opioids, and among individuals under varying conditions. To effectively rotate from one opioid to another, the new opioid must be started at a dose that will cause neither toxicity nor abstinence, and will be sufficiently efficacious in that pain is no worse than before the change. The estimate of relative potency used in calculating this starting dose has been codified on "equianalgesic dose tables," which historically have been based on the best science available and have been used with little modification for more than 40 years. These tables, and the clinical protocols used to apply them to opioid rotation, may need revision, however, as the science underlying relative potency evolves. Review of these issues informs the use of opioid rotation in the clinical setting and defines key areas for future research.

摘要

阿片类药物转换是指从一种阿片类药物转换为另一种阿片类药物,以改善镇痛治疗反应或减少不良反应。这是一种解决尽管进行了最佳剂量滴定但阿片类药物反应性仍较差问题的常用方法。阿片类药物转换指南是经验性的,首先要为新的阿片类药物选择一个安全且合理有效的起始剂量,然后进行剂量调整以优化镇痛与副作用之间的平衡。起始剂量的选择必须基于对现有阿片类药物和新阿片类药物之间相对效价的估计。效价定义为产生给定效应所需的剂量,在不同阿片类药物之间以及在不同条件下的个体之间差异很大。为了有效地从一种阿片类药物转换为另一种阿片类药物,新的阿片类药物必须以既不会引起毒性也不会导致戒断反应的剂量开始使用,并且其疗效要足够好,即疼痛程度不比换药前更严重。用于计算此起始剂量的相对效价估计已编入“等效镇痛剂量表”,这些表格历来基于现有最佳科学依据,并且在40多年的时间里几乎没有修改就一直被使用。然而,随着相对效价背后的科学不断发展,这些表格以及用于将其应用于阿片类药物转换的临床方案可能需要修订。对这些问题的审查为临床环境中阿片类药物转换的使用提供了参考,并确定了未来研究的关键领域。

相似文献

1
Opioid rotation: the science and the limitations of the equianalgesic dose table.阿片类药物转换:等效镇痛剂量表的科学依据与局限性
J Pain Symptom Manage. 2009 Sep;38(3):426-39. doi: 10.1016/j.jpainsymman.2009.06.001.
2
Opioid equianalgesic tables: are they all equally dangerous?阿片类等效镇痛量表:它们都同样危险吗?
J Pain Symptom Manage. 2009 Sep;38(3):409-17. doi: 10.1016/j.jpainsymman.2009.06.004.
3
Opioid rotation in the management of chronic pain: where is the evidence?阿片类药物转换在慢性疼痛管理中的应用:有何证据?
Pain Pract. 2010 Mar-Apr;10(2):85-93. doi: 10.1111/j.1533-2500.2009.00335.x. Epub 2010 Jan 8.
4
Establishing "best practices" for opioid rotation: conclusions of an expert panel.确立阿片类药物轮换的“最佳实践”:专家小组的结论
J Pain Symptom Manage. 2009 Sep;38(3):418-25. doi: 10.1016/j.jpainsymman.2009.06.002.
5
Opioid rotation in clinical practice.临床实践中的阿片类药物转换。
Adv Ther. 2012 Oct;29(10):849-63. doi: 10.1007/s12325-012-0051-7. Epub 2012 Sep 25.
6
Opioid conversions in acute care.急性护理中的阿片类药物转换
Ann Pharmacother. 2007 Feb;41(2):255-66. doi: 10.1345/aph.1H421. Epub 2007 Feb 13.
7
Opioid switching and rotation in primary care: implementation and clinical utility.基层医疗中的阿片类药物转换与轮换:实施与临床应用
Curr Med Res Opin. 2009 Sep;25(9):2133-50. doi: 10.1185/03007990903120158.
8
Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.急性姑息治疗病房中阿片类药物转换的频率、适应症、结果及预测因素。
J Pain Symptom Manage. 2009 Apr;37(4):632-41. doi: 10.1016/j.jpainsymman.2007.12.024.
9
Clinical implications of opioid pharmacogenetics.阿片类药物药物遗传学的临床意义。
Clin J Pain. 2010 Jan;26 Suppl 10:S16-20. doi: 10.1097/AJP.0b013e3181c49e11.
10
Combination opioid analgesics.复方阿片类镇痛药
Pain Physician. 2008 Mar-Apr;11(2):201-14.

引用本文的文献

1
Inadequate Cancer Pain Control after Switching High-Dose Fentanyl to Hydromorphone Injection: A Case Series Highlighting Issues with Conventional Conversion Ratios.从大剂量芬太尼转换为氢吗啡酮注射后癌症疼痛控制不足:一个突出传统转换比例问题的病例系列
Palliat Med Rep. 2025 Sep 1;6(1):408-414. doi: 10.1177/10966218251366061. eCollection 2025.
2
Reflecting on Cancer Pain as Constant Acute Pain, not Chronic Pain. 'Known Knowns, Known Unknowns, Unknown Unknowns'.将癌症疼痛视为持续性急性疼痛而非慢性疼痛。“已知的已知、已知的未知、未知的未知”。
Curr Oncol Rep. 2025 May;27(5):584-600. doi: 10.1007/s11912-025-01642-w. Epub 2025 Apr 3.
3
Methadone in the madness: a case series and review of methadone management in hospital settings.
美沙酮在疯狂中的应用:病例系列及医院环境中美沙酮管理的综述
Pain Manag. 2025 Apr;15(4):191-198. doi: 10.1080/17581869.2025.2479411. Epub 2025 Mar 31.
4
Opioid conversion in adults with cancer: MASCC-ASCO-AAHPM-HPNA-NICSO guideline.成人癌症患者的阿片类药物转换:MASCC-ASCO-AAHPM-HPNA-NICSO指南
Support Care Cancer. 2025 Mar 3;33(3):243. doi: 10.1007/s00520-025-09286-z.
5
Effects of transcutaneous electrical nerve stimulation on acute postoperative breast augmentation pain: study protocol.经皮电刺激神经对隆胸术后急性疼痛的影响:研究方案
Pain Manag. 2024 Dec;14(12):611-618. doi: 10.1080/17581869.2024.2434450. Epub 2024 Nov 26.
6
The effects of photobiomodulation and transcutaneous electrical nerve stimulation on chronic neck pain: A double-blind, randomized, sham-controlled trial.光生物调节和经皮电刺激神经疗法对慢性颈部疼痛的影响:一项双盲、随机、假对照试验。
Braz J Phys Ther. 2024 Nov-Dec;28(6):101124. doi: 10.1016/j.bjpt.2024.101124. Epub 2024 Nov 6.
7
Distributed Opioids in Morphine Equivalent: A Global Measure of Availability for Palliative Care.以吗啡当量计的分布式阿片类药物:姑息治疗可及性的全球衡量指标
J Pain Symptom Manage. 2025 Feb;69(2):204-215. doi: 10.1016/j.jpainsymman.2024.10.026. Epub 2024 Oct 28.
8
Opioid analgesic dose and route conversion ratio studies: a scoping review to inform an eDelphi guideline.阿片类镇痛药剂量和给药途径换算比研究:一项范围综述,为电子德尔菲指南提供信息。
Support Care Cancer. 2024 Jul 24;32(8):542. doi: 10.1007/s00520-024-08710-0.
9
The PATIENT Approach: A New Bundle for the Management of Chronic Pain.患者治疗方法:一种慢性疼痛管理的新组合方案
J Pers Med. 2023 Oct 29;13(11):1551. doi: 10.3390/jpm13111551.
10
Prevalence of opioid-induced adverse events across opioids commonly used for analgesic treatment in Japan: a multicenter prospective longitudinal study.日本常用于镇痛治疗的阿片类药物所致不良反应的发生率:一项多中心前瞻性纵向研究。
Support Care Cancer. 2023 Oct 16;31(12):632. doi: 10.1007/s00520-023-08099-2.